← FDA Drug Approvals (Drugs@FDA)
DICLOFENAC POTASSIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALKEM LABS LTD · Approved 2022-07-20
Drug application
- FDA Application #
ANDA216635- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DICLOFENAC POTASSIUM
- Generic name
- DICLOFENAC POTASSIUM
- Active ingredients
- DICLOFENAC POTASSIUM
- Dosage form
- FOR SOLUTION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ALKEM LABS LTD
- Manufacturer
- Ascend Laboratories, LLC
- First approval
- 2022-07-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown